Long-term Treatment of Deep Venous Thrombosis with a Low Molecular Weight Heparin (Tinzaparin): A Prospective Randomized Trial
- 1 June 2005
- journal article
- clinical trial
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 29 (6) , 638-650
- https://doi.org/10.1016/j.ejvs.2004.02.029
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Three Months versus One Year of Oral Anticoagulant Therapy for Idiopathic Deep Venous ThrombosisNew England Journal of Medicine, 2001
- Incidence of Recurrent Thromboembolic and Bleeding Complications Among Patients With Venous Thromboembolism in Relation to Both Malignancy and Achieved International Normalized Ratio: A Retrospective AnalysisJournal of Clinical Oncology, 2000
- Assessment of Outpatient Treatment of Deep-Vein Thrombosis With Low-Molecular-Weight HeparinArchives of internal medicine (1960), 1998
- Low-Molecular-Weight HeparinsNew England Journal of Medicine, 1997
- Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT)The Lancet, 1996
- Treatment of Venous Thrombosis with Intravenous Unfractionated Heparin Administered in the Hospital as Compared with Subcutaneous Low-Molecular-Weight Heparin Administered at HomeNew England Journal of Medicine, 1996
- Low-molecular-weight heparins and unfractionated heparin in the treatment of patients with acute venous thromboembolism: Results of a meta-analysisThe American Journal of Medicine, 1996
- Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated HeparinNew England Journal of Medicine, 1995
- Treatment of Deep Venous Thrombosis With Low-Molecular-Weight HeparinsArchives of internal medicine (1960), 1995
- Maternal and fetal sequelae of anticoagulation during pregnancyThe American Journal of Medicine, 1980